开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
A Japan-listed Brazil ETF tumbled 11% after President Lula won re-election.
2026-10-26
A Japan-listed Brazil ETF tumbled 11% after President Lula won re-election.
返回
其他消息
2026-10-26
港股芯片股多数下跌,华虹宏力(01347.HK)跌超7%,ASMPT(00522.HK)跌超6%,壁仞科技(06082.HK)、天数智芯(09903.HK)、兆易创新(03986.HK)跌超5%。
港股芯片股多数下跌,华虹宏力(01347.HK)跌超7%,ASMPT(00522.HK)跌超6%,壁仞科技(06082.HK)、天数智芯(09903.HK)、兆易创新(03986.HK)跌超5%。
2026-10-25
Pfizer said an experimental antibody‑drug conjugate, sigvotatug vedotin, failed to meet the primary endpoint in a trial of unresectable advanced lung cancer, showing no overall survival benefit versus chemotherapy. In a post‑hoc analysis presented at ESMO on Sunday, Pfizer reported that a subgroup of less‑heavily pretreated patients receiving the drug in combination showed survival more than two months longer than the chemotherapy control. Pfizer, which acquired the asset when it bought Seagen f
Pfizer said an experimental antibody‑drug conjugate, sigvotatug vedotin, failed to meet the primary endpoint in a trial of unresectable advanced lung cancer, showing no overall survival benefit versus chemotherapy. In a post‑hoc analysis presented at ESMO on Sunday, Pfizer reported that a subgroup of less‑heavily pretreated patients receiving the drug in combination showed survival more than two months longer than the chemotherapy control. Pfizer, which acquired the asset when it bought Seagen for $43 bln and had expected it to be a first‑in‑class product, said it will continue to pursue development and combination strategies.
Chat with us
, powered by
LiveChat